BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
319.12
-2.24 (-0.70%)
At close: Aug 18, 2025, 3:59 PM
321.00
0.59%
After-hours: Aug 18, 2025, 07:51 PM EDT
-0.70% (1D)
| Bid | 318.62 |
| Market Cap | 34.1B |
| Revenue (ttm) | 4.56B |
| Net Income (ttm) | -177.64M |
| EPS (ttm) | -1.7 |
| PE Ratio (ttm) | -187.72 |
| Forward PE | 46.5 |
| Analyst | Buy |
| Ask | 322.04 |
| Volume | 566,494 |
| Avg. Volume (20D) | 375,508 |
| Open | 321.36 |
| Previous Close | 321.36 |
| Day's Range | 318.34 - 330.43 |
| 52-Week Range | 170.99 - 330.43 |
| Beta | 0.27 |
Analyst Forecast
According to 0 analyst ratings, the average rating for ONC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BeOne Medicines Ltd. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-2.84%
ONC stock has given up its prior gain. BeOne Medic...
Unlock content with
Pro Subscription
1 week ago
-2.84%
BeOne Medicines shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance.
1 week ago · fool.com
BeOne Medicines (ONC) Q2 EPS Soars 924%BeOne Medicines (ONC) Q2 EPS Soars 924%
